Gates Foundation, Wellcome Pledge $550M for Phase III Trial of GSK’s TB Vaccine

For the first time in over a century, the world could potentially see a new tuberculosis vaccine. The Bill & Melinda Gates Foundation and Wellcome announced Wednesday that they will fund an international clinical trial of an experimental TB vaccine candidate developed by GSK involving 26,000 people in Africa and Southeast Asia.